Entrar

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur group transfer to the substrate, and sulfated metabolite creation. Various drugs, including those containing phenols, alcohols, arylamines, N-hydroxylamines, and N-hydroxyamides (such as acetaminophen, minoxidil, and morphine), undergo sulfation. The resulting sulfoconjugates are pharmacologically active and may cause tissue damage or carcinogenesis.

α-amino acid conjugation, another phase II reaction, involves linking a drug to an α-amino acid like glycine or glutamine. This reaction is catalyzed by acyltransferases. The reaction mechanism involves activating the α-amino acid, its transfer to the drug substrate, and the formation of the conjugated metabolite. Drugs with aliphatic, alicyclic, aryl, or heterocyclic aryl acids, such as salicylic and valproic acids, undergo α-amino acid conjugation.

Tags

Phase II ReactionsSulfationConjugationBiotransformationDrug MetabolismSulfate GroupWater SolubilityGlucuronidationSulfotransferase EnzymesPAPS CoenzymeSulfated MetabolitePharmacologically ActiveTissue DamageCarcinogenesisAcyltransferasesAmino Acid Conjugation

Do Capítulo 5:

article

Now Playing

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

107 Visualizações

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

161 Visualizações

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

210 Visualizações

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

109 Visualizações

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

44 Visualizações

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

152 Visualizações

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

46 Visualizações

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

108 Visualizações

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

142 Visualizações

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

89 Visualizações

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

120 Visualizações

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

72 Visualizações

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

25 Visualizações

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

112 Visualizações

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

71 Visualizações

JoVE Logo

Privacidade

Termos de uso

Políticas

Pesquisa

Educação

SOBRE A JoVE

Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados